SHANGHAI JUNSHI BIO YC1 Net Asset Quality Index
SHANGHAI JUNSHI BIO YC1 net asset quality index. SHANGHAI JUNSHI BIO YC1 (8SJ) has a Net Asset Quality Index of 49.0% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €12.40 Billion minus total liabilities of €6.33 Billion yields net assets of €6.07 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See what is SHANGHAI JUNSHI BIO YC1's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of SHANGHAI JUNSHI BIO YC1 (2021–2025)
Net asset quality index of SHANGHAI JUNSHI BIO YC1 from 2021 to 2025. This chart shows how SHANGHAI JUNSHI BIO YC1's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 49.0%, representing net assets of €6.07 Billion against total assets of €12.40 Billion EUR. Check how tangible is SHANGHAI JUNSHI BIO YC1's equity to evaluate the tangible quality of the company's equity base.
SHANGHAI JUNSHI BIO YC1 Net Asset Quality Index by Year (2021–2025)
SHANGHAI JUNSHI BIO YC1 net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for SHANGHAI JUNSHI BIO YC1 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of SHANGHAI JUNSHI BIO YC1.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 49.0% | €6.07 Billion | €12.40 Billion | €6.33 Billion | ▼ -6.1 pp |
| 2024 | 55.1% | €5.95 Billion | €10.80 Billion | €4.85 Billion | ▼ -9.5 pp |
| 2023 | 64.6% | €7.34 Billion | €11.36 Billion | €4.02 Billion | ▼ -13.3 pp |
| 2022 | 77.9% | €9.79 Billion | €12.58 Billion | €2.78 Billion | ▲ +2.5 pp |
| 2021 | 75.4% | €8.33 Billion | €11.05 Billion | €2.72 Billion | — |